Expression of Squamous Cell Carcinoma Markers and Adenocarcinoma Markers in Primary Pulmonary Neuroendocrine Carcinomas-Reference-Cited by-同舟云学术

Expression of Squamous Cell Carcinoma Markers and Adenocarcinoma Markers in Primary Pulmonary Neuroendocrine Carcinomas

Published:2013-07 Issue:4 Volume:21 Page:292-297
ISSN:1541-2016
Container-title:Applied Immunohistochemistry & Molecular Morphology
language:en
Short-container-title:

Author:

Masai Kyohei,Tsuta Koji,Kawago Mitsumasa,Tatsumori Takahiro,Kinno Tomoaki,Taniyama Tomoko,Yoshida Akihiko,Asamura Hisao,Tsuda Hitoshi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Medical Laboratory Technology,Histology,Pathology and Forensic Medicine

Reference6 articles.

1. Separation of small-cell from non-small-cell lung cancer. The South- eastern Cancer Study Group pathologists experience.;Vollmer;Arch Pathol Lab Med,1984

2. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK56.;Mukhopadhyay;Am J Surg Pathol,2011

3. Sox2 expression in pulmonary non small cell and neuroendocrine carcinomas.;Sholl;Appl Immunohistochem Mol Morphol,2010

4. Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma.;Ueno;Br J Cancer,2003

5. Histopathologic classification of lung cancer: relevance of cytokeratin and TTF-1 immunophenotyping.;Johansson;Ann Diagn Pathol,2004

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transformation or tumor heterogeneity: Mutations in EGFR, SOX2, TP53, and RB1 persist in the histological rapid conversion from lung adenocarcinoma to small‐cell lung cancer;Thoracic Cancer;2023-02-21

2. Updates in pathology and molecular diagnostics to inform the evolving landscape of thoracic surgery and oncology;Journal of Surgical Oncology;2023-01-11

3. Pleuropulmonary and Mediastinal Neoplasms;Handbook of Practical Immunohistochemistry;2022

4. Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2021-12

5. Immunocytochemistry for diagnostic cytopathology—A practical guide;Cytopathology;2021-06-03